Browse 3 pharmaceutical patent law cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
Federal Circuit Affirms Non-Infringement of Patent for Drug Formulation Treatment
Wright v. Collins, decided by Federal Circuit on August 1, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient's condition using a specifi...
CAFC Affirms Non-Infringement of Ophthalmic Drug Patent
Eye Therapies, LLC v. Slayback Pharma LLC, decided by Federal Circuit on June 30, 2025, resulted in a defendant win outcome. The core dispute centered on whether Slayback Pharma LLC's proposed generic...
Federal Circuit Affirms Patent Infringement for Narcolepsy Drug Dosing
Jazz Pharmaceuticals, Inc. v. Avadel Cns Pharmaceuticals, LLC, decided by Federal Circuit on May 6, 2025, resulted in a plaintiff win outcome. The Federal Circuit affirmed the District of Delaware's g...
CaseLawBrief currently tracks 3 pharmaceutical patent law cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 2, Plaintiff Win: 1.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.